References
- Sonis S T. Oral complications of cancer chemotherapy. Cancer. 2nd edition Principles and practice of oncology, V T DeVita, S Hellman, S A Rosenberg. JB Lippincott Co. 1985; 2014–21
- Peterson D E, Sonis S T. Oral complications of cancer chemotherapy. Cancer Treat Rep 1982; 66: 1251–6
- Nagashima R. Development and characteristics of sucralfate. J Clin Gastroenterol 1981; 3: 103–10
- Nagashima R. Mechanism of action of sucralfate. J Clin Gastroenterol 1981; 3: 117–27
- Scott Brooks W, Jr. Sucralfate: Nonulcer use. Am J Gastroenterol 1985; 80: 206–9
- Pfeiffer P, Madsen E L, Hansen O, May O. Effect of prophylactic sucralfate suspension on chemotherapy induced mucositis of the oral cavity: A prospective randomized, double-blind cross-over study. Acta Oncol, (Accepted for publication.)
- Tarnawski A. Sucralfate, is it more than just a barrier. Curr Conc Gastroenterol 1984; 1: 5–12
- Tarnowski A. Effect of sucralfate on normal gastric mucosa. Gastroenterology 1983; 1331, (Abstr)
- Solomon M A. Oral sucralfate suspension for mucositis. N Eng J Med 1986; 315: 459–60
- Ferraro J M, Mattern J QA. Sucralfate suspension for stomatitis. Drug Intel Clin Pharm 1984; 18: 153
- Henriksson R, Franzén L, Littbrand B. Does sucralfate reduce radiation-induced diarrhea. Acta Oncol 1987; 26: 76–7
- Kochhar R, Sharma S C, Gupta B B, Mehta S K. Rectal sucralfate in radiation proctitis. Lancet 1988; 2: 400
- Coates A, Dillenbeck C, McNeil D R, et al. On the receiving end—II. Linear analogue selfassessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy. Eur J Cancer Clin Oncol 1983; 19: 1633–7
- Epstein J B, Stevenson-Moore P. Benzydamine hydrochloride in prevention and management of pain in oral mucositis associated with radiation therapy. Oral Surg Oral Med Oral Pathol 1986; 62: 145–8